21 related articles for article (PubMed ID: 9918560)
1. Cutaneous endothelin-A receptors elevate post-incisional pain.
Mujenda FH; Duarte AM; Reilly EK; Strichartz GR
Pain; 2007 Dec; 133(1-3):161-73. PubMed ID: 17467172
[TBL] [Abstract][Full Text] [Related]
2. Primary active transport of peptidic endothelin antagonists by rat hepatic canalicular membrane.
Akhteruzzaman S; Kato Y; Hisaka A; Sugiyama Y
J Pharmacol Exp Ther; 1999 Feb; 288(2):575-81. PubMed ID: 9918561
[TBL] [Abstract][Full Text] [Related]
3. Carrier-mediated hepatic uptake of peptidic endothelin antagonists in rats.
Akhteruzzaman S; Kato Y; Kouzuki H; Suzuki H; Hisaka A; Stieger B; Meier PJ; Sugiyama Y
J Pharmacol Exp Ther; 1999 Sep; 290(3):1107-15. PubMed ID: 10454484
[TBL] [Abstract][Full Text] [Related]
4. Hepatobiliary transport mechanism for the cyclopentapeptide endothelin antagonist BQ-123.
Shin HC; Kato Y; Yamada T; Niinuma K; Hisaka A; Sugiyama Y
Am J Physiol; 1997 May; 272(5 Pt 1):G979-86. PubMed ID: 9176204
[TBL] [Abstract][Full Text] [Related]
5. Hepatobiliary transport of a nonpeptidic endothelin antagonist, (+)-(5S,6R,7R)-2-butyl-7-[2((2S)-2-carboxypropyl)-4-methoxyphenyl]-5-(3,4-methylenedioxyphenyl) cyclopentenol[1,2-b]pyridine-6-carboxylic acid: uptake by isolated rat hepatocytes and canalicular membrane vesicles.
Kobayashi N; Tani T; Hisaka A; Hara K; Yasumori T
Pharm Res; 2003 Jan; 20(1):89-95. PubMed ID: 12608541
[TBL] [Abstract][Full Text] [Related]
6. Carrier-mediated active transport of BQ-123, a peptidic endothelin antagonist, into rat hepatocytes.
Nakamura T; Hisaka A; Sawasaki Y; Suzuki Y; Fukami T; Ishikawa K; Yano M; Sugiyama Y
J Pharmacol Exp Ther; 1996 Aug; 278(2):564-72. PubMed ID: 8768705
[TBL] [Abstract][Full Text] [Related]
7. Membrane transport as a determinant of the hepatic elimination of drugs and metabolites.
Evans AM
Clin Exp Pharmacol Physiol; 1996; 23(10-11):970-4. PubMed ID: 8911743
[TBL] [Abstract][Full Text] [Related]
8. Nanoparticle-liver interactions: Cellular uptake and hepatobiliary elimination.
Zhang YN; Poon W; Tavares AJ; McGilvray ID; Chan WCW
J Control Release; 2016 Oct; 240():332-348. PubMed ID: 26774224
[TBL] [Abstract][Full Text] [Related]
9. Hepatobiliary transport governs overall elimination of peptidic endothelin antagonists in rats.
Kato Y; Akhteruzzaman S; Hisaka A; Sugiyama Y
J Pharmacol Exp Ther; 1999 Feb; 288(2):568-74. PubMed ID: 9918560
[TBL] [Abstract][Full Text] [Related]
10. [Kinetic analysis of hepatobiliary transport of drugs: importance of carrier-mediated transport].
Yamazaki M; Nishigaki R; Suzuki H; Sugiyama Y
Yakugaku Zasshi; 1995 Dec; 115(12):953-77. PubMed ID: 8587036
[TBL] [Abstract][Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
